metricas
covid
Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) Microbiology of Surgical Site Infections in Abdominal Tract Surgery Patients
Información de la revista
Vol. 89. Núm. 9.
Páginas 606-612 (noviembre 2011)
Visitas
7421
Vol. 89. Núm. 9.
Páginas 606-612 (noviembre 2011)
Original Article
Acceso a texto completo
Microbiology of Surgical Site Infections in Abdominal Tract Surgery Patients
Microbiología de las infecciones del sitio quirúrgico en pacientes intervenidos del tracto digestivo
Visitas
7421
Elena Múñeza, Antonio Ramosa,
Autor para correspondencia
aramos220@gmail.com

Corresponding author.
, Teresa Álvarez de Espejoa, Josep Vaquéb, José Sánchez-Payác, Vicente Pastord, Ángel Asensioe
a Servicio de Medicina Interna (Unidad de Infecciosas), Universidad Autónoma de Madrid, Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, Spain
b Servicio de Medicina Preventiva, Hospital Vall d‘Hebron, Barcelona, Spain
c Servicio de Medicina Preventiva, Hospital General Universitario de Alicante, Alicante, Spain
d Servicio de Medicina Preventiva, Hospital Universitario de La Princesa, Madrid, Spain
e Servicio de Medicina Preventiva, Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, Spain
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Tablas (4)
Table 1. Aetiology of Surgical Infections in Patients Undergoing Abdominal Surgery According to Infection Location.
Table 2. Surgery Time for Patients Undergoing Upper or Lower Digestive Tract Abdominal Surgery.
Table 3. Risk Factors Associated With Nosocomial Infections in Patients Undergoing Upper or Lower Digestive Tract Abdominal surgery.
Table 4. Aetiology of Surgical Infections in Patients Undergoing Upper or Lower Digestive Tract Abdominal Surgery.
Mostrar másMostrar menos
Abstract
Introduction

Knowledge of the microbiology of surgical infections after abdominal surgery can be of use when prescribing effective empirical antibiotic treatments.

Method

Analysis of surgical infections after abdominal surgery in patients enrolled in the Prevalence of Infections in Spanish Hospitals (EPINE) corresponding to the years 1999–2006.

Results

During the period of the study, 2280 patients who were subjected to upper or lower abdominal tract surgery were diagnosed with an infection at the surgical site (SSI). Eight hundred and eighty-three patients (37%) had an operation of the upper abdominal tract (gastric, hepatobiliary, and pancreatic surgery) and 1447 patients (63%) had lower abdominal tract surgery (appendectomy and colon surgery). A total of 2617 bacterial species were isolated in the 2280 patients included in the analysis. The most frequent microorganisms isolated were, Escherichia coli (28%), Enterococcus spp. (15%), Streptococcus spp. (8%), Pseudomonas aeruginosa (7%), and Staphylococcus aureus (5%, resistant to methicillin 2%). In the surgical infections after upper abdominal tract procedures, there were a higher proportion of isolations of staphylococci, Klebsiella pneumoniae, Enterobacter spp., Acinetobacter spp. and Candida albicans and less E. coli, Bacteroides fragilis and Clostridium spp.

Conclusion

The microbiology of SSI produced after upper abdominal tract surgery did not show any significant differences compared to those of the lower tract. However, more cases of SSI were detected due to staphylococci, K. pneumoniae, Enterobacter spp., Acinetobacter spp. and C. albicans and less caused by E. coli, B. fragilis and Clostridium spp.

Keywords:
General surgery
Surgical wound infection
Peritonitis
Microbiology
Methicillin resistant Staphylococcus aureus
Resumen
Introducción

El conocimiento de la microbiología de las infecciones quirúrgicas tras cirugía abdominal puede contribuir a la prescripción de regímenes de tratamiento antibiótico empírico eficaces.

Método

Análisis de las infecciones quirúrgicas tras cirugía abdominal en pacientes incluidos en el estudio de prevalencia de infecciones en hospitales españoles (EPINE) correspondiente a los años 1999-2006.

Resultados

Durante el período de tiempo considerado en el estudio se diagnosticaron 2.280 pacientes con infección del sitio quirúrgico (ISQ) que había sido sometidos a cirugía del tracto digestivo superior o inferior. Ochocientos treinta y tres pacientes (37%) habían sido intervenidos del tracto abdominal superior (cirugía gástrica, hepatobiliar y pancreática) y 1.447 pacientes (63%) del inferior (apendicectomía y cirugía de colon). Se aislaron 2.617 especies bacterianas en los 2280 pacientes incluidos en el análisis. Los microorganismos aislados con más frecuencia fueron Escherichia coli (28%), Enterococcus spp. (15%), Streptococcus spp. (8%), Pseudomonas aeruginosa (7%), y Staphylococcus aureus (5%, resistentes a meticilina 2%). En las infecciones quirúrgicas tras procedimientos digestivos altos hubo una mayor proporción de aislamientos de estafilococos, Klebsiella pneumoniae, Enterobacter spp., Acinetobacter spp. y Candida albicans y menor de Escherichia coli, Bacteroides fragilis y Clostridium spp.

Conclusión

La microbiología de las ISQ producidas tras intervenciones del tracto digestivo superior no mostró diferencias acusadas en relación a las del tracto inferior. No obstante, se detectaron más casos de ISQ debidos a estafilococos, Klebsiella pneumoniae, Enterobacter spp., Acinetobacter spp. y Candida albicans y menos causados por Escherichia coli, Bacteroides fragilis y Clostridium spp.

Palabras clave:
Cirugía general
Infección de la herida quirúrgica
Peritonitis
Microbiología
Staphylococcus aureus resistente a meticilina
Texto completo
Introduction

Despite advances in antisepsis and operating technique, surgical site infections (SSI) are a considerable problem for patients undergoing gastrointestinal surgery.1–3 These infections can affect all areas, from the skin and subcutaneous tissue to deeper structures of the abdominal cavity.1,4 Their appearance usually leads to increased hospital stay and may jeopardise the patient's life.1,4,5 Most studies have found some incidence of SSI after abdominal surgery, with values ranging between 3% and 20%.1,6–8 Certain circumstances, such as patient comorbidity, degree of contamination of the surgical field and duration of the intervention may modify the chance of acquiring SSI.7,9,10 Other factors related to these infections include age, nutritional status, obesity and preoperative preparation.1,11

Factors such as hospital stay and prior antibiotic therapy may influence the microbiology of the SSI observed.8,12,13 Due to the increased frequency of antibiotic-resistant bacteria, in these complications both the antibiotic prophylaxis administered and empirical therapy used may not be appropriate in some cases.14

The aim of this study was to investigate the microbiology of surgical infections occurring after gastrointestinal tract surgery in a representative sample of Spanish hospitals.

Method

The information was obtained from the database of the prevalence studies of nosocomial infections in Spanish hospitals (EPINE). This is an annual survey conducted in a large sample of Spanish hospitals which gathers clinical information about both patients and their infections.15

This study selected patients included in the EPINE study who had developed surgical infection after abdominal surgery during the period 1999–2006. To determine the aetiology of the infections depending on their location (incision, organ, or space), the infections occurring in patients undergoing abdominal cavity interventions performed in general surgery departments were considered (this included both interventions with a low risk of infection, such as groin hernia surgery or splenectomy, and large bowel procedures). A comparison was then made between patients with upper digestive tract surgery (gastric, pancreatic and hepatobiliary surgery) and those with lower digestive tract surgery (appendectomy and colorectal surgery). This section did not include infections detected after other surgical procedures, such as those of the small intestine, as the flora that causes infections in this location may vary depending on their proximal or distal location.

The diagnosis of infection and categorisation of surgical procedures were performed according to the Centers for Disease Control criteria.16 Operating risk was assessed according to ASA.17 Data from the EPINE study were taken from patient medical records, nursing records, and directly from the patient and attending professionals, when necessary. The results of microbiological studies and other complementary tests were especially examined.

The main variables collected from patients who had an infection in the review were age, sex, infection location, microbiological aetiology, and a set of intrinsic and extrinsic risk factors.1,4,8,15

Categorical variables were expressed as percentages; continuous variables were expressed as mean and standard deviation. To evaluate the differences in means in the univariate analysis, the non-parametric Mann–Whitney test was used. To compare categorical variables, the Fisher's exact test was used if the sample was less than 5, and the Chi-square test if not. Statistical significance was a P value with a tail less than .05.

Results

The number of Spanish hospitals participating in the EPINE study has increased progressively, exceeding 250 hospitals after 2001. Institutions from all Spanish regions participated in the study. There were 3461 SSI cases detected in the group of patients with abdominal cavity surgery operated upon in general surgery departments, and 3955 microorganisms were isolated. The microbiology test results are detailed in Table 1 by infection location.

Table 1.

Aetiology of Surgical Infections in Patients Undergoing Abdominal Surgery According to Infection Location.

  Superficial IncisionDeep IncisionOrgan or Space InfectionsP 
Gram-Positive Cocci  n=1108  n=1362  n=1485   
Staphylococcus aureus  90  8.1  93  4.1  61  6.9  <.001 
MRSAa  33  43  1.7  25  3.2  .034 
CNS  65  5.9  75  4.6  69  5.5  .351 
Streptococcus spp.  77  6.9  95  7.2  106  .978 
Streptococcus agalactiaea  7  0.6  5  0.3  4  0.4  .343e 
Viridans Streptococcusa  43  3.9  45  4.1  61  3.3  .516 
Enterococcus spp.  159  14.4  192  15.7  232  14.1  .447 
Enterococcus faecalisa  106  9.6  125  9.2  136  9.2  .927 
Enterococcus faeciuma  24  2.2  40  3.5  52  2.9  .130 
Anaerobic gram-positive cocci
Clostridium perfringens  0.2  0.4  0.3  .788 
Clostridium spp.  0.2  0.4  0.6  .441 
Peptostreptococcus spp.  0.1  0.7  10  0.4  .153 
Gram-positive bacilli
Propionibacterium spp.  0.1  .867 
Corynebacterium spp.  11  13  0.7  11  .750 
Gram-negative bacilli, enterobacteriaceae
Escherichia coli  321  29  372  22.8  339  27.3  <.001 
Klebsiella spp.  40  3.6  40  4.5  67  2.9  .083 
Klebsiella pneumoniaea  21  1.9  26  2.6  39  1.9  .319 
Klebsiella oxytocaa  18  1.6  12  1.8  26  0.9  .114 
Enterobacter spp.  36  3.3  55  4.6  69  4.1  .202 
Enterobacter aerogenesa  0.4  0.8  12  0.6  .347 
Enterobacter cloacaea  27  2.4  39  3.7  55  2.9  .157 
Proteus spp.  37  3.4  54  4.3  65  3.9  .405 
Proteus mirabilisa  32  2.9  42  3.6  54  3.1  .525 
Citrobacter freundii  10  0.9  11  1.3  20  0.8  .319 
Citrobacter spp.  0.2  0.5  0.4  .339 
Serratia marcescens  0.5  0.1  .052 
Serratia spp.  0.3  0.1  .365 
Providencia spp.  0.1  0.1  0.2  .945 
Providencia stuartiia  0.1  0.1  0.1  .932 
Morganella morgagnii  39  3.5  38  1.5  23  2.8   
Gram-negative bacilli (not enterobacteriaceae)
Pseudomonas aeruginosa  64  5.8  98  119  7.2  .005 
Pseudomonas spp.  0.3  0.1  0.4  .667 
Acinetobacter baumannii  0.8  12  1.1  16  0.9  .760 
Acinetobacter spp.  0.4  0.5  0.2  .324 
Stenotrophomonas maltophilia  0.2  0.3  0.4  .679 
Non-fermentative gram-negative bacilli  0.1  .592 
Anaerobic bacilli
Bacteroides fragilis group  32  2.9  35  3.7  55  2.6  .196 
Bacteroides (not fragilis10  0.9  17  15  1.2  .685 
Prevotella spp.  0.3  0.8  12  0.5  .295 
Other bacteria  32  2.9  53  4.6  68  3.9  .088 
Moulds
Candida spp.  56  5.1  58  5.5  81  4.3  .329 
Candida albicansa  42  3.8  42  59  3.1  .416 

MRSA: S. aureus resistant to methicillin; CNS: coagulase-negative staphylococci.

a

The number of isolates was counted in the row corresponding to its type.

During the study period, 2280 cases of surgical infection were diagnosed, with upper abdominal tract surgery accounting for 833 cases and lower abdominal tract surgery accounting for 1447 cases. The SSI was superficial in 718 patients (31%), deep in 695 patients (30%), and it was an infection in an organ or space, such as peritonitis or intraabdominal abscess, in 866 patients (38%). There were 946 women (41%), and the mean age was 60.9 years (median 67, range 6–97 years). Antibiotic prophylaxis was performed in 78% of patients. The duration of the intervention was greater than 180min in 586 patients (26%, Table 2), and 41% of the patients had an ASA operating risk ≥3. The potential risk factors studied which are associated with hospital surgery are described in Table 3. There were a high proportion of patients suffering from diabetes mellitus (40%), renal failure (21%), obesity (14%) and neoplastic disease (12%). Extrinsic factors present at diagnosis included central venous catheter (42%), urinary catheter (36%), parenteral nutrition (28%), nasogastric probe (24%) and mechanical ventilation (11%), see Table 3.

Table 2.

Surgery Time for Patients Undergoing Upper or Lower Digestive Tract Abdominal Surgery.

Intervention Durationa  No. 
≤60min  306  13.4 
61–120min  736  32.3 
121–180min  543  23.8 
>180min  586  25.7 
a

The intervention time was not recorded in 109 cases (4.8%).

Table 3.

Risk Factors Associated With Nosocomial Infections in Patients Undergoing Upper or Lower Digestive Tract Abdominal surgery.

Intrinsic Risk Factors  No. 
Obesity  328  14.4 
Malnutrition  276  12.1 
Kidney failure  48  21 
Diabetes mellitus  914  40.1 
Neoplasia  267  11.7 
Chronic lung disease  59  2.6 
Cirrhosis  48  2.1 
Immunodeficiency  27  1.2 
Extrinsic risk factors
Urinary probe  826  36.2 
Central catheter  954  42.3 
Parenteral nutrition  629  27.9 
Mechanical ventilation  242  10.6 
Nasogastric probe  543  23.8 
Immunosuppressive drugs  144  6.3 
Pharmacological sedation  78  3.4 

Some 2617 bacterial species were isolated from the 2280 patients included in the analysis, of which 60% were gram-negative bacilli and 32% gram-positive cocci. The most frequently isolated microorganisms were Escherichia coli (28%), Enterococcus spp. (15%), Streptococcus spp. (8%), Pseudomonas aeruginosa (7%), coagulase-negative staphylococci (5%), Staphylococcus aureus (5%, 2% were methicillin-resistant), Candida spp. (4%), Klebsiella spp. (4%), Enterobacter spp. (4%), Proteus mirabilis (3%) and Bacteroides fragilis (3%).

Patients with surgical infection after proximal gastrointestinal procedures had a higher proportion of staphylococci isolates (Klebsiella pneumoniae, Enterobacter spp., Acinetobacter spp. and Candida albicans) and lower proportion of E. coli, B. fragilis and Clostridium spp. (Table 4).

Table 4.

Aetiology of Surgical Infections in Patients Undergoing Upper or Lower Digestive Tract Abdominal Surgery.

Microorganism  Upper Digestive TractLower Digestive TractP 
  n=985  n=1632   
Gram-positive cocci
Staphylococcus aureus  63  6.4  68  4.2  .010 
MRSAa  30  24  1.5  .006 
CNS  80  8.1  59  3.6  <.001 
Streptococcus spp.  69  130  .369 
Streptococcus agalactiaea  0.1  0.5  .099 
Viridans Streptococcusa  43  4.4  64  3.9  .578 
Enterococcus spp.  146  14.8  260  15.9  .447 
Enterococcus faecalisa  89  165  10.1  .368 
Enterococcus faeciuma  35  3.6  51  3.1  .551 
Anaerobic gram-positive cocci
Clostridium perfringens  0.3  0.4  .789 
Clostridium spp.  0.5  .027 
Peptostreptococcus spp.  0.4  0.3  .906 
Gram-positive bacilli
Propionibacterium spp.  0.1  .409 
Corynebacterium spp.  0.9  15  0.9  .998 
Gram-negative bacilli
Escherichia coli  192  19.5  554  33.9  <.001 
Klebsiella spp.  43  4.3  52  3.2  .118 
Klebsiella pneumoniaea  28  2.8  24  1.5  .016 
Klebsiella oxytocaa  14  1.4  25  1.5  .821 
Enterobacter spp.  58  5.9  38  2.3  <.001 
Enterobacter aerogenesa  0.9  0.3  .039 
Enterobacter cloacaea  46  4.7  28  1.7  <.001 
Proteus spp.  30  72  4.4  .080 
Proteus mirabilisa  24  2.4  62  3.8  .058 
Citrobacter freundii  14  1.4  0.5  .011 
Citrobacter spp.  0.4  0.6  .608 
Serratia marcescens  0.5  0.0  .004 
Serratia spp.  0.1  0.1  .611 
Providencia stuartii  0.1  .376 
Morganella morganii  29  2.9  40  2.5  .445 
Gram-negative bacilli (not enterobacteriaceae)
Pseudomonas aeruginosa  69  103  6.3  .487 
Pseudomonas spp.  0.1  0.2  .378 
Acinetobacter baumannii  15  1.5  10  0.6  .020 
Acinetobacter spp.  0.5  0.2  .138 
Stenotrophomonas maltophilia  0.4  0.1  .141 
Non-fermentative gram-negative bacilli  0.1  .623 
Anaerobic bacilli
Bacteroides fragilis group  16  1.6  65  <.001 
Bacteroides (not fragilis0.9  15  0.9  .998 
Prevotella spp.  0.6  0.5  .686 
Other bacteria  42  4.3  56  3.4  .277 
Moulds
Candida spp.  67  6.8  39  2.4  <.001 
Candida albicansa  48  4.9  30  1.8  <.001 

MRSA: S. aureus resistant to methicillin; CNS: coagulase-negative staphylococci.

a

The number of isolates was counted in the row corresponding to its type.

Discussion

The results obtained from the EPINE study give a global view of the microbiology of postoperative infections in Spanish hospitals.15 The high average age and frequency of concurrent chronic diseases along with extrinsic risk factors highlight the clinical complexity of many cases of abdominal surgical infection.14,18

Among the species isolated from patients with SSI after abdominal surgery are gram-negative bacilli of gastrointestinal origin (aerobic and anaerobic) and gram-positive species, such as streptococci, staphylococci and enterococci, which is consistent with similar studies.19–21 A high proportion of patients who developed enterococcal infection had received cefazolin (which is not active against Enterococcus), which may favour its appearance.14,23,24 Empirical antibiotic coverage for enterococci is considered essential for nosocomial infections, as opposed to that recommended for community-acquired infections.25,26 The proportion of Enterococcus faecium (which is usually resistant to beta-lactams) was higher than that in previous studies.27

A significant proportion of isolates corresponded to pathogens commonly contracted in hospitals, such as gram-negative non-fermenters, methicillin-resistant S. aureus (MRSA) and Enterobacter.13,22 In more than 6% of the cultures Pseudomonas were isolated, which is important in the prescription of empirical antibiotic treatment in postoperative abdominal infection cases, especially in patients with risk factors such as prior antibiotic therapy or septic shock.13,28

The microbiology of superficial infection was generally similar to deep infections. The only exception was that infections with S. aureus were more frequent and those with P. aeruginosa less frequent in superficial incisional infections. Also E. coli was isolated less frequently in deep incisional areas than for the other 2 types of infection. However, unlike that observed by other authors, in a large number of patients MRSA infections were found in the organ and space areas.29

The microbiology of surgical infections after upper tract surgery was broadly similar to those after lower digestive tract interventions.30 This result would theoretically justify the use of a similar empirical antibiotic treatment in both circumstances to provide adequate coverage for enterobacteriaceae, anaerobes and enterococci.14 Among the differences found between both groups of infections was a greater presence of staphylococci in upper tract infections.13 Furthermore, the isolation of E. coli and anaerobic bacteria (B. fragilis in particular) was found more often after lower tract surgery. This was expected due to the native flora in each digestive location.30,31 A higher proportion of enterococci infections in the lower tract was not found, as described previously.30,31

The Candida species accounted for 4% of the isolates. They have been associated with stomach and duodenum surgical procedures, anaerobic antibiotic coverage, lack of intra-abdominal focus control and higher mortality.32,33 These yeasts participated more frequently in upper tract surgical procedures than that in lower tract ones, which is consistent with the data in this study.30,32Candida was isolated in a significant proportion of organ and space infections, which confirms the growing importance of fungi in postoperative peritonitis (14%).34 This has prompted the recommendation for empirical use of antifungal agents in patients with risk factors.14,35

The marked diversity of pathogens potentially involved in these infections highlights the risk of inappropriate empirical therapy, which usually occurs in 13%–16% of intra-abdominal infections and could lead to increased mortality.3,36,37 Sometimes this is due to infections caused by resistant gram-negative bacteria (producing extended-spectrum or AmpC beta-lactamases), beta-lactam- or vancomycin-resistant enterococci or Candida.38 The prevalence of AmpC-type beta-lactamases increases after the use of cephalosporins (and other antibiotics) which are generally used in antibiotic prophylaxis. The progressive increase in community-acquired infections caused by ESBL-producing enterobacteria should also be noted.39,40 The most important factor for developing postoperative peritonitis due to multidrug-resistant microorganisms is receiving antibiotic treatment after the initial surgery.12 The prescription of an appropriate empirical regimen in some patients could be a combination of an antipseudomonal carbapenem (with or without aminoglycoside) and a glycopeptide.12,14 However, it is very important to know the epidemiology of each institution to establish the most suitable empirical treatment for each patient.12,14

Being a prevalence study (analysing the number of patients admitted with an infection on a given day), the incidence of these infections could not be obtained, which is one of the limitations of this study. It should also be added that these results may not be applied to specific hospitals, with their individual epidemiological features, as this was a national study. This survey also did not include other variables that may have been of interest, such as smoking use, preoperative stay, type of antibiotic prophylaxis administered, degree of compliance with adequate preoperative preparation or the NNIS index. In addition, the relationship between infection aetiology and pre-surgery antibiotic treatment or the degree of contamination was not able to be analysed. The microbiology of infections in patients undergoing elective surgery was not able to be compared with that for urgent surgery or that related to reinterventions. These may be caused by nosocomial microorganisms, with increased antimicrobial resistance. Another limitation is that infections after hepatobiliary surgery were not independently studied. These may present significant differences to those produced in other types of upper digestive tract interventions.

In conclusion, the microbiology of SSI occurring after upper gastrointestinal interventions showed no marked differences to those in the lower tract. However, more cases of SSI were detected due to staphylococci, K. pneumoniae, Enterobacter spp., Acinetobacter spp. and C. albicans, and less were caused by E. coli, B. fragilis and Clostridium spp. The information obtained from this study allows a better understanding of the aetiology of surgical infections in patients undergoing abdominal surgery, which may have epidemiological and therapeutic implications.

Conflicts of Interest

The authors have no conflicts of interest to declare.

References
[1]
J.P. Kirby, J.E. Mazuski.
Prevention of surgical site infection.
Surg Clin N Am, 89 (2009), pp. 365-389
[2]
T.G. Emori, R.P. Gaynes.
An overview of nosocomial infections, including the role of the microbiology laboratory.
Clin Microbiol Rev, 6 (1993), pp. 428-442
[3]
R.L. Smith, J.K. Bohl, S.T. McElearney, C.M. Friel, M.M. Barclay, R.G. Sawyer, et al.
Wound infection after elective colorectal resection.
Ann Surg, 239 (2004), pp. 599-607
[4]
D.E. Fry.
The economic costs of surgical site infection.
Surg Infect (Larchmt), 3 (2002), pp. S37-S43
[5]
P. Pessaux, S. Msika, D. Atalla, J.M. Hay, Y. Flamant.
French Association for Surgical Research Risk factors for postoperative infectious complications in noncolorectal abdominal surgery: a multivariate analysis based on a prospective multicenter study of 4718 patients.
Arch Surg, 138 (2003), pp. 314-324
[6]
D.H. Culver, T.C. Horan, R.P. Gaynes, W.J. Martone, W.R. Jarvis, T.G. Emori, et al.
Surgical wound infection rates by wound class, operative procedure, and patient risk index.
Am J Med, 91 (1991), pp. 152S-157S
[7]
J.R. Edwards, K.D. Peterson, M.L. Andrus, M.A. Dudeck, D.A. Pollock, T.C. Horan.
National Healthcare Safety Network Facilities, National Healthcare Safety Network (NHSN) Report, data summary for 2006 through 2007, issued November 2008.
Am J Infect Control, 36 (2008), pp. 609-626
[8]
M. Haridas, M.A. Malangoni.
Predictive factors for surgical site infection in general surgery.
Surgery, 144 (2008), pp. 496-501
[9]
J.J. Iñigo, B. Bermejo, B. Oronoz, J. Herrera, A. Tarifa, F. Pérez, et al.
Infección de sitio quirúrgico en un servicio de cirugía general, Análisis de cinco años y valoración del índice National Nosocomial Infection Surveillance (NNIS).
Cir Esp, 79 (2006), pp. 224-230
[10]
C.A. Weiss, C.L. Statz, R.A. Dahms, M.J. Remucal, D.L. Dunn, G.J. Beilman.
Six years of surgical wound infection surveillance at a tertiary care center: review of the microbiologic and epidemiological aspects of 20,007 wounds.
Arch Surg, 134 (1999), pp. 1041-1048
[11]
A.J. Mangram, T.C. Horan, M.L. Pearson, L.C. Silver, W.R. Jarvis.
Guideline for prevention of surgical site infection, 1999.
Infect Control Hosp Epidemiol, 20 (1999), pp. 250-278
[12]
P. Augustin, N. Kermarrec, C. Muller-Serieys, S. Lasocki, D. Chosidow, J.P. Marmuse, et al.
Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis.
Crit Care, 14 (2010), pp. R20
[13]
P. Montravers, A. Lepape, L. Dubreuil, R. Gauzit, Y. Pean, D. Benchimol, et al.
Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study.
J Antimicrob Chemother, 63 (2009), pp. 785-794
[14]
X. Guirao, J. Arias, J.M. Badía, J.A. García-Rodríguez, J. Mensa, F. Alvarez-Lerma, et al.
Recomendaciones en el tratamiento antibiótico empírico de la infección intraabdominal.
[15]
A. Asensio, R. Cantón, J. Vaqué, J. Rosselló, J.L. Arribas.
Etiología de las infecciones hospitalarias en España (EPINE, 1990–1999).
Med Clin (Barc), 118 (2002), pp. 725-730
[16]
T.C. Horan, R.P. Gaunes, W.J. Martone, W.R. Jarvis, T.G. Emori.
CDC definitions of nosocomial surgical site infection, 1992. A modification of CDC definitions of surgical wound infections.
Infect Control Hosp Epidemiol, 13 (1992), pp. 606-608
[17]
J.S. Garner, W.R. Jarvis, T.G. Emori, T.C. Horan, J.M. Hughes.
CDC definitions for nosocomial infections, 1988.
Am J Infect Control, 16 (1988), pp. 128-140
[18]
P. Vázquez-Aragon, M. Lizan-García, P. Cascales-Sánchez, M.T. Villar-Canovas, D. Garcia-Olmo.
Nosocomial infection and related risk factors in a general surgery service: a prospective study.
J Infect, 46 (2003), pp. 17-22
[19]
B. Schnüriger, K. Inaba, B.M. Eberle, T. Wu.
Microbiological profile and antimicrobial susceptibility in surgical site infections following hollow viscus injury.
J Gastrointest Surg, 14 (2010), pp. 1304-1310
[20]
D. Mosdell, D. Morris, A. Voltura, D. Pitcher, M. Twiest, R. Milne, et al.
Antibiotic treatment for surgical peritonitis.
Ann Surg, 214 (1991), pp. 543-549
[21]
J. Tellado, S. Sen, M. Caloto, R. Kumar, G. Nocea.
Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community-acquired intra-abdominal infections in Spain.
Scand J Infect Dis, 39 (2007), pp. 947-955
[22]
A. Roehrborn, L. Thomas, O. Potreck, C. Ebener, C. Ohmann, P.E. Goretzki, et al.
The microbiology of postoperative peritonitis.
Clin Infect Dis, 33 (2001), pp. 1513-1519
[23]
J.M. Cisneros, J. Rodríguez-Baño, J. Mensa, A. Trilla, M. Cainzos.
Profilaxis con antimicrobianos en cirugía.
Enferm Infecc Microbiol Clin, 20 (2002), pp. 335-340
[24]
R.A. Dahms, E.M. Johnson, C.L. Statz, J.T. Lee, D.L. Dunn, G.J. Beilman, et al.
Third generation cephalo-sporins and vancomycin as risk factors for postoperative vancomycin resistant enterococcus infection.
Arch Surg, 133 (1998), pp. 1343-1346
[25]
E. Cercenado, L. Torroba, R. Cantón, L. Martínez-Martínez, F. Chaves, J.A. García-Rodríguez, et al.
Multicenter study evaluating the role of enterococci in secondary bacterial peritonitis.
J Clin Microbiol, 48 (2010), pp. 456-459
[26]
R. Burnett, D. Haverstock, E. Dellinger, H.H. Reinhart, J.M. Bohnen, O.D. Rotstein, et al.
Definition of the role of Enterococcus in intraabdominal infection: analysis of a prospective randomized trial.
Surgery, 118 (1995), pp. 716-723
[27]
A. Sitges-Serra, M. Lopez, M. Girvent, S. Almirall, J. Sancho.
Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis.
[28]
P. Berthelot, F. Grattard, P. Mahul, P. Pain, R. Jospé, C. Venet, et al.
Prospective study of nosocomial colonization and infection due to Pseudomonas aeruginosa in mechanically ventilated patients.
Intensive Care Med, 27 (2001), pp. 503-512
[29]
A. Kumar, D. Roberts, K. Wood, B. Light, J. Parrillo, S. Sharma, et al.
Duration of hypotension before initiation of effective anti-microbial therapy is the critical determinant of survival in human septic shock.
Crit Care Med, 34 (2006), pp. 1589-1596
[30]
J.S. Solomkin, J.E. Mazuski, E.J. Baron, R.G. Sawyer, A.B. Nathens, J.T. DiPiro, et al.
Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.
Clin Infect Dis, 37 (2003), pp. 997-1005
[31]
M. Qadan, W.G. Cheadle.
Common microbial pathogens in surgical practice.
Surg Clin N Am, 89 (2009), pp. 295-310
[32]
B.R. Swenson, R. Metzger, T.L. Hedrick, S.T. McElearney, H.L. Evans, R.L. Smith, et al.
Choosing antibiotics for intra-abdominal infections: what do we mean by “high risk”?.
Surg Infect (Larchmt), 10 (2009), pp. 29-39
[33]
P. Montravers, H. Dupont, R. Gauzit, B. Veber, C. Auboyer, P. Blin, et al.
Candida as a risk factor for mortality in peritonitis.
Crit Care Med, 34 (2006), pp. 646-652
[34]
J. Nolla-Salas, a.A. Sitges-Serr, C. León-Gil, J. Martínez-González, M. León-Regidor, P. Ibáñez-Lucia, et al.
Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy.
Intensive Care Med, 23 (1997), pp. 23-30
[35]
J. Vincent, E. Anaissie, H. Bruining, W. Demajo, M. el-Ebiary, J. Haber, et al.
Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients underintensive care.
Intensive Care Med, 24 (1998), pp. 206-216
[36]
M. Baré, CastellsX, A. García, M. Riu, M. Comas, M. Gil-Egea.
Importance of appropriateness of empirical antibiotic therapy on clinical outcomes in intra-abdominal infections.
Int J Technol Assess Health Care, 22 (2006), pp. 242-248
[37]
M. Sturkenboom, W. Goettsch, G. Picelli, B. Veld, D. Yin, R. de Jong, et al.
Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs.
Br J Clin Pharmacol, 60 (2005), pp. 438-443
[38]
E. Ibrahim, G. Sherman, S. Ward, V. Frase, M. Kollef.
The influence of inadequate antimicrobial treatment of bloodstream infections on patients outcomes in the ICU setting.
Chest, 118 (2000), pp. 146
[39]
F. Baquero, E. Cecenado, R. Cisterna, M.M. de la Rosa, J.A. García-Rodríguez, M. Gobernado, et al.
Patrones de sensiblidad a antimicrobianos en enterobacterias causantes de infecciones intraabdominales en España: resultados del estudio SMART 2003.
Rev Esp Quimioter, 19 (2006), pp. 51-59
[40]
R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, et al.
Prevalence and spread of extended-spectrum b-lactamase producing enterobacteriaceae in Europe.
Clin Microbiol Infect, 14 (2008), pp. 144-153

Please, cite this article as: Múnez E, et al. Microbiología de las infecciones del sitio quirúrgico en pacientes intervenidos del tracto digestivo. Cir Esp. 2011;89:606–12.

Copyright © 2011. AEC
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos